Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric studyArticle Published on 2022-10-212022-11-15 Journal: Medicine [Category] [DOI] 10.1097/MD.0000000000031288 PMC 바로가기
Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant RecipientsArticle Published on 2022-10-092022-11-15 Journal: Viruses [Category] [DOI] 10.3390/v14102224 PMC 바로가기
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort studyArticle Published on 2022-10-052022-11-15 Journal: BMC Medicine [Category] [DOI] 10.1186/s12916-022-02587-8 PMC 바로가기
Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs HospitalsArticle Published on 2022-10-032022-11-15 Journal: JAMA Network Open [Category] [DOI] 10.1001/jamanetworkopen.2022.40037 PMC 바로가기
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 VaccinationArticle Published on 2022-09-282022-11-15 Journal: Viruses [Category] [DOI] 10.3390/v14102143 PMC 바로가기
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease종양 괴사 인자-α 길항제의 사용은 염증성 장 질환이 있는 백신 접종 환자에서 SARS-CoV-2에 대한 약화된 IgG 항체 반응과 관련이 있습니다Observational Study Published on 2022-07-052022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.920333 PMC 바로가기 [Article Type] Observational Study
Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case ReportArticle Published on 2022-07-012022-11-15 Journal: Transplantation proceedings [Category] [DOI] 10.1016/j.transproceed.2022.04.015 PMC 바로가기
Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions실생활에서 자가면역 염증성 류마티스 질환 환자의 코로나19 예방접종에 대한 체액 및 세포 반응Observational Study Published on 2022-06-282022-09-12 Journal: Rheumatology (Oxford, England) [Category] [DOI] 10.1093/rheumatology/keac089 PMC 바로가기 [Article Type] Observational Study
Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trialObservational Study Published on 2022-06-222022-10-05 Journal: European Journal of Medical Research [Category] [DOI] 10.1186/s40001-022-00727-7 PMC 바로가기 [Article Type] Observational Study
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort염증성 류마티스 질환 환자에서 BNT162b2 Anti-SARS-CoV-2 백신 접종에 대한 혈청학적 반응: RHEUVAX 코호트의 결과Article Published on 2022-06-172022-09-12 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.901055 PMC 바로가기 [Article Type] Article